Pure Global

Rapid Antigen Self Testing Kit for COVID-19 - India CDSCO Medical Device Registration

Rapid Antigen Self Testing Kit for COVID-19 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000150_dda12582ddbecd9fbac11c194f894f83_0cf3e06db79346a927b7faff14fc6107. The license holder is NeoDx Biotech Labs Pvt Ltd, and it is classified as Device Class Class C. The approving authority is Sub Zonal Bangalore.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Rapid Antigen Self Testing Kit for COVID-19
UID: MFG/IVD/2020/000150_dda12582ddbecd9fbac11c194f894f83_0cf3e06db79346a927b7faff14fc6107

Device Class

Class C

Approving Authority

Sub Zonal Bangalore

Product Information

NeoCheck Rapid Antigen Self Test Kit is an In-vitro diagnostic immunochromatographic rapid antigen test kit for the qualitative detection of SARS-CoV-2 in symptomatic & asymptomatic individuals. This test is authorized for non-prescription home use, by any user (NA) in a private setting, to aid in the diagnosis of an active SARS-CoV-2 infection. The self-collected nasal swab specimens from individuals 18 years and above, can be used to perform the test. In case of individuals in the range 2 - 18 years, the test must be performed under adult supervision. Collecting the nasal swab sample, and conduct of the procedure is to be performed by the supervising adult

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (1)
Other products with the same name or brand